Example: Heart Attack

Search clinical trials for: Orlistat

Total 61 results

NCT04417582

Recruiting

Life Style Modification Medical and Surgical Management in Patients With Obesity

Conditions: Obesity; Weight Change, Body; Obesity; Endocrine; Obesity, Metabolically Benign
NCT03884127

Not yet recruiting

Ezetimibe and Orlistat Affect the Intestinal Flora of Hyperlipidemia.

Conditions: Hyperlipidemia
NCT03799198

Completed

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

Conditions: Obesity
NCT03736551

Unknown status

Intermittent Low Energy Diet in CKD: MIX UP Feasibility Study

Conditions: Chronic Kidney Diseases; Obesity
NCT03675191

Completed

Orlistat/Phentermine Versus Placebo/Phentermine

Conditions: Obesity; Overweight
NCT03582722

Recruiting

Weight Loss Aid in an Exposed Population

Conditions: Polybrominated Biphenyl Poisoning
NCT03430284

Recruiting

Multifactorial Intervention on Diabetes (MIDiab Study)

Conditions: Diabetes Mellitus, Type 2
NCT03383068

Unknown status

Research of Intensive Metabolic Intervention Before Pregnancy in PCOS

Conditions: PCOS; Impaired Glucose Tolerance
NCT03336086

Completed

Effect of Weight Reduction on Immunity

Conditions: Lymphocytes; Weight Loss; Viral Diseases; Immunity; Anti-obesity Agents
NCT02767531

Active, not recruiting

Orlistat for the Treatment of Type I Hyperlipoproteinemia

Conditions: Hyperlipoproteinemia Type I; Hypertriglyceridemia
NCT02706067

Completed

Multifactorial Approach Associated With Orlistat (Xenical) for 4 Years Weight Loss Maintenance in Obese Adults

Conditions: Obesity
NCT02541487

Enrolling by invitation

Fetal Effects of Pre-Pregnancy Lifestyle Interventions in Unexplained Infertility Patients

Conditions: Infertility
NCT02529631

Completed

RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

Conditions: Overweight; Obesity
NCT02503865

Completed

Development of Rational Ways of Medical and Non-medical Treatment Methods for Metabolic Syndrome

Conditions: Metabolic Syndrome
NCT02432209

Completed

Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained Infertility

Conditions: Infertility, Female
NCT02372526

Unknown status

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

Conditions: Bariatric Surgery (Gastric Bypass); Overweight
NCT02141230

Withdrawn

Risk Management Plan (RMP) Survey for Purchasers of Alli® (60 mg Orlistat) in the European Union.

Conditions: Weight Loss
NCT02069197

Recruiting

Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

Conditions: Obesity; Diabetes; Obstructive Sleep Apnea
NCT02041234

Active, not recruiting

Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment

Conditions: Type II Diabetes in Subjects BMI 27 to 32
NCT01797757

Completed

Comparison of MAG and Fish Oil Efficacy

Conditions: Obesity
NCT01755676

Completed

Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

Conditions: Obesity
NCT01719419

Withdrawn

The Effect of Modified Sham Feeding With Orlistat in Overweight and Obese Subjects

Conditions: Overweight
NCT01675154

Active, not recruiting

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

Conditions: Type 1 Hyperlipoproteinemia
NCT01597531

Terminated

Combinatorial Therapy for Peristent Type 2 Diabetes After Gastric Banding

Conditions: Type 2 Diabetes; Gastric Banding
NCT01550926

Completed

A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms

Conditions: Overweight
NCT01475019

Unknown status

The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)

Conditions: Obesity; Polycystic Ovaries Syndrome
NCT01414465

Completed

Orlistat Induced Modulation on the Fatty Acid Composition in Obese Females

Conditions: Overweight
NCT01387243

Completed

Survey on the Pharmacy Follow-up of Alli Purchasers

Conditions: Overweight
NCT01351753

Terminated

Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity

Conditions: Obesity; Metabolic Syndrome X
NCT01332448

Completed

Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials

Conditions: Obesity
NCT01320228

Completed

Effect of Dietary Components on Gastrointestinal Side Effects Induced by Orlistat, a Lipase Inhibitor

Conditions: Obesity
NCT01184560

Completed

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

Conditions: Obesity
NCT01170806

Completed

Study of Fat Malabsorption by Lipiblock Versus Xenical

Conditions: Obesity
NCT01128400

Completed

Fat Perception in Humans (09-0873)

Conditions: Obesity
NCT01126970

Completed

Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects

Conditions: Obesity
NCT01053130

Completed

Weight Loss Interventions in Obese Patients With Stages 3-4 Chronic Kidney Disease: a Randomised Controlled Trial

Conditions: Chronic Kidney Disease; Obesity
NCT01047657

Completed

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Conditions: Asthma; Obesity; Weight Loss
NCT01035333

Completed

A Pilot Study of the Efficacy of Alli in the Management of Pre-operative Weight Loss Required for Bariatric Surgery.

Conditions: Obesity
NCT01003483

Completed

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Conditions: Obesity
NCT00991926

Completed

Growth Factor/Insulin-like Growth Factor (GH/IGF)-1 Axis in Obese Subjects in Treatment With Orlistat

Conditions: Obesity
NCT00940628

Completed

A Study of Xenical (Orlistat) in Overweight and Obese Adolescents

Conditions: Obesity
NCT00871845

Terminated

Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients

Conditions: Obesity; Insulin Resistance; Metabolic Syndrome; Hepatitis C
NCT00829283

Completed

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Conditions: Obesity; Binge Eating
NCT00794963

Terminated

Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

Conditions: Metabolic Syndrome
NCT00752726

Completed

Effect of Orlistat in Body Composition

Conditions: Obesity; Overweight
NCT00704912

Completed

Treatment of Hyperandrogenism Versus Insulin Resistance in Infertile Polycystic Ovary Syndrome (PCOS) Women

Conditions: Polycystic Ovary Syndrome
NCT00601354

Completed

Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating Disorder

Conditions: Overweight; Eating Disorders
NCT00541762

Completed

Regulation of Fat-stimulated Neurotensin Secretion in Healthy Subjects

Conditions: Healthy
NCT00533481

Completed

Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)

Conditions: Obesity
NCT00516919

Completed

Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons

Conditions: Obesity; Binge Eating

Search clinical trials for: Orlistat

Recent CRA jobs

Business Intelligence Analyst

Clinical Project Manager / Senior Clinical Project Manager (home-based) -- Early Clinical Development

Clin Data Prgmg Assoc 1

BI Architect

Business Intelligence/DWH Architect

Internship in Clinical Research (m/w/d) – office based in Basel – 6-month contract

Clin Data Coord 2

Assoc Clin Data Coder

Medisch afgevaardigde natuurlijke producten Gent + Waasland

Medical Laboratory Assistant